Global Single-Cell Genome Sequencing Market Research Report 2024
Published on: 2024-01-04 | No of Pages : 400 | Industry : Medical
Publisher : MRA | Format : PDF
Global Single-Cell Genome Sequencing Market Research Report 2024
Single cell sequencing examines the sequence information from individual cells with optimized next-generation sequencing (NGS) technologies, providing a higher resolution of cellular differences and a better understanding of the function of an individual cell in the context of its microenvironment.
According to MRAResearch’s new survey, global Single-Cell Genome Sequencing market is projected to reach US$ 1608.4 million in 2033, increasing from US$ 893.9 million in 2022, with the CAGR of 8.3% during the period of 2023 to 2033. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Single-Cell Genome Sequencing market research.
Key companies engaged in the Single-Cell Genome Sequencing industry include Bio-Rad Laboratories, 10x Genomics, Novogene, Fluidigm, BGI, Illumina, Inc., Oxford Nanopore Technologies, Pacific Biosciences and Thermo Fisher Scientific, Inc., etc. Among those companies, the top 3 players guaranteed % supply worldwide in 2022.
When refers to consumption region, % value of Single-Cell Genome Sequencing were sold to North America, Europe and Asia Pacific in 2022. Moreover, China, plays a key role in the whole Single-Cell Genome Sequencing market and estimated to attract more attentions from industry insiders and investors.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2023-2033), aims to help readers to get a comprehensive understanding of global Single-Cell Genome Sequencing market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
![](http//localhost/mraccuracy/images/Market%20Recearch%20Graph.jpg)
Bio-Rad Laboratories
10x Genomics
Novogene
Fluidigm
BGI
Illumina, Inc.
Oxford Nanopore Technologies
Pacific Biosciences
Thermo Fisher Scientific, Inc.
QIAGEN
F Hoffmann-La Roche Ltd.
Segment by Type
NGS
PCR
qPCR
Microarray
MDA
CTCs
Differentiation/ reprogramming
Genomic variation
Subpopulation characterization
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
The Single-Cell Genome Sequencing report covers below items
Chapter 1Product Basic Information (Definition, Type and Application)
Chapter 2Global market size, regional market size. Market Opportunities and Challenges
Chapter 3Companies’ Competition Patterns
Chapter 4Product Type Analysis
Chapter 5Product Application Analysis
Chapter 6 to 10Country Level Value Analysis
Chapter 11Companies' Outline
Chapter 12Market Conclusions
Chapter 13Research Methodology and Data Source![](http://localhost/mraccuracy/images/About Report.webp)
According to MRAResearch’s new survey, global Single-Cell Genome Sequencing market is projected to reach US$ 1608.4 million in 2033, increasing from US$ 893.9 million in 2022, with the CAGR of 8.3% during the period of 2023 to 2033. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Single-Cell Genome Sequencing market research.
Key companies engaged in the Single-Cell Genome Sequencing industry include Bio-Rad Laboratories, 10x Genomics, Novogene, Fluidigm, BGI, Illumina, Inc., Oxford Nanopore Technologies, Pacific Biosciences and Thermo Fisher Scientific, Inc., etc. Among those companies, the top 3 players guaranteed % supply worldwide in 2022.
When refers to consumption region, % value of Single-Cell Genome Sequencing were sold to North America, Europe and Asia Pacific in 2022. Moreover, China, plays a key role in the whole Single-Cell Genome Sequencing market and estimated to attract more attentions from industry insiders and investors.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2023-2033), aims to help readers to get a comprehensive understanding of global Single-Cell Genome Sequencing market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
![](http//localhost/mraccuracy/images/Market%20Recearch%20Graph.jpg)
By Company
Bio-Rad Laboratories
10x Genomics
Novogene
Fluidigm
BGI
Illumina, Inc.
Oxford Nanopore Technologies
Pacific Biosciences
Thermo Fisher Scientific, Inc.
QIAGEN
F Hoffmann-La Roche Ltd.
Segment by Type
NGS
PCR
qPCR
Microarray
MDA
Segment by Application
CTCs
Differentiation/ reprogramming
Genomic variation
Subpopulation characterization
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
The Single-Cell Genome Sequencing report covers below items
Chapter 1Product Basic Information (Definition, Type and Application)
Chapter 2Global market size, regional market size. Market Opportunities and Challenges
Chapter 3Companies’ Competition Patterns
Chapter 4Product Type Analysis
Chapter 5Product Application Analysis
Chapter 6 to 10Country Level Value Analysis
Chapter 11Companies' Outline
Chapter 12Market Conclusions
Chapter 13Research Methodology and Data Source
![](http://localhost/mraccuracy/images/About Report.webp)